Literature DB >> 3312009

Role of lipopolysaccharide and complement in susceptibility of Klebsiella pneumoniae to nonimmune serum.

B Ciurana1, J M Tomás.   

Abstract

The role of lipopolysaccharide (LPS) in the susceptibility of Klebsiella pneumoniae to serum and the mechanism of complement activation by serum-susceptible (SerS) strains were investigated. The classical and alternative complement pathways are involved in serum killing of susceptible K. pneumoniae strains. The LPS composition seems to play a very important role in the serum bactericidal reaction, while capsular polysaccharide from this bacterium does not play any role. High-molecular-weight LPS from serum-resistant (Serr) K. pneumoniae strains was able to inhibit completely the serum bactericidal activity. LPS from SerS K. pneumoniae strains was not able to inhibit completely the serum bactericidal activity; low-molecular-weight LPS from Serr K. pneumoniae strains could not either. All these findings suggested that LPS composition, especially the O-antigen polysaccharide chains, contributes to the susceptibility of K. pneumoniae strains to complement-mediated serum bactericidal activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3312009      PMCID: PMC259970          DOI: 10.1128/iai.55.11.2741-2746.1987

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  The survival of strains of enteric bacilli in the blood stream as related to their sensitivity to the bactericidal effect of serum.

Authors:  R J ROANTREE; N C PAPPAS
Journal:  J Clin Invest       Date:  1960-01       Impact factor: 14.808

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Activation of complement via the alternative pathway.

Authors:  M K Pangburn
Journal:  Fed Proc       Date:  1983-01

4.  C3 shunt activation in human serum chelated with EGTA.

Authors:  D P Fine; S R Marney; D G Colley; J S Sergent; R M Des Prez
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

5.  The sensitivity to complement of strains of Escherichia coli related to their K antigens.

Authors:  A A Glynn; C J Howard
Journal:  Immunology       Date:  1970-03       Impact factor: 7.397

6.  Differential complement resistance mediates virulence of Haemophilus influenzae type b.

Authors:  A Sutton; R Schneerson; S Kendall-Morris; J B Robbins
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

7.  Sensitivity of rough gram-negative bacteria to the bactericidal action of serum.

Authors:  D Rowley
Journal:  J Bacteriol       Date:  1968-05       Impact factor: 3.490

8.  Protein composition of the outer membrane of Salmonella typhimurium: effect of lipopolysaccharide mutations.

Authors:  G F Ames; E N Spudich; H Nikaido
Journal:  J Bacteriol       Date:  1974-02       Impact factor: 3.490

9.  Plasmid-determined resistance to serum bactericidal activity: a major outer membrane protein, the traT gene product, is responsible for plasmid-specified serum resistance in Escherichia coli.

Authors:  A Moll; P A Manning; K N Timmis
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

10.  Serum-resistant mutants of Escherichia coli O111 contain increased lipopolysaccharide, lack an O antigen-containing capsule, and cover more of their lipid A core with O antigen.

Authors:  R C Goldman; K Joiner; L Leive
Journal:  J Bacteriol       Date:  1984-09       Impact factor: 3.490

View more
  19 in total

1.  Mechanisms of Klebsiella pneumoniae resistance to complement-mediated killing.

Authors:  S Merino; S Camprubí; S Albertí; V J Benedí; J M Tomás
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

2.  Mesophilic Aeromonas sp. serogroup O:11 resistance to complement-mediated killing.

Authors:  S Merino; X Rubires; A Aguilar; S Albertí; S Hernandez-Allés; V J Benedí; J M Tomas
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

3.  Analysis of complement C3 deposition and degradation on Klebsiella pneumoniae.

Authors:  S Albertí; D Alvarez; S Merino; M T Casado; F Vivanco; J M Tomás; V J Benedí
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

Review 4.  Immunotherapy in the management of sepsis.

Authors:  E A Fagan; M Singer
Journal:  Postgrad Med J       Date:  1995-02       Impact factor: 2.401

5.  C1q binding and activation of the complement classical pathway by Klebsiella pneumoniae outer membrane proteins.

Authors:  S Albertí; G Marqués; S Camprubí; S Merino; J M Tomás; F Vivanco; V J Benedí
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

Review 6.  Klebsiella pneumoniae: Going on the Offense with a Strong Defense.

Authors:  Michelle K Paczosa; Joan Mecsas
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-15       Impact factor: 11.056

7.  Increased serum resistance in Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases.

Authors:  H Sahly; H Aucken; V J Benedí; C Forestier; V Fussing; D S Hansen; I Ofek; R Podschun; D Sirot; J M Tomás; D Sandvang; U Ullmann
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

8.  Sialic acid-containing lipopolysaccharides of Salmonella O48 strains--potential role in camouflage and susceptibility to the bactericidal effect of normal human serum.

Authors:  Gabriela Bugla-Płoskońska; Jacek Rybka; Bozena Futoma-Kołoch; Agnieszka Cisowska; Andrzej Gamian; Włodzimierz Doroszkiewicz
Journal:  Microb Ecol       Date:  2009-10-21       Impact factor: 4.552

9.  Altering the length of the lipopolysaccharide O antigen has an impact on the interaction of Salmonella enterica serovar Typhimurium with macrophages and complement.

Authors:  Gerald L Murray; Stephen R Attridge; Renato Morona
Journal:  J Bacteriol       Date:  2006-04       Impact factor: 3.490

Review 10.  Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors.

Authors:  R Podschun; U Ullmann
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.